Terumo Interventional Systems (TIS), a division of Terumo Corporation, has introduced the R2P NaviCross peripheral support catheter to the U.S. market. This strategic launch aims to bolster Terumo’s radial-to-peripheral (R2P) portfolio, addressing the growing need for advanced tools in complex interventional procedures.
Advanced Design Meets Clinical Needs
The newly launched R2P NaviCross catheter measures 200 cm in length and boasts a double-braided stainless-steel construction. This design enhances trackability and torque control, enabling physicians to navigate and cross challenging lesions with greater precision. Ghada Farah, Division President of TIS, emphasized that this product responds directly to customer requests for longer, high-performance catheters, reinforcing Terumo’s commitment to meeting clinical demands.
Expanding the R2P Product Line
The R2P NaviCross complements Terumo’s existing R2P offerings, which include the Destination Slender guiding sheath and the SlenGuide guiding catheter. Michael J. Martinelli, MD, FACC, FSCAI, Chief Medical Officer at Terumo Medical Corporation, highlighted that the 200 cm length allows for more effective percutaneous transluminal endovascular procedures from the radial artery. This addition empowers interventionalists to handle both simple and complex lesions above and below the knee, enhancing procedural safety and efficiency.
Key Inferences:
- Enhanced maneuverability facilitates treatment of complex peripheral lesions.
- Integration with existing R2P tools provides a comprehensive procedural toolkit.
- Supports the increasing demand for minimally invasive PAD and critical limb ischemia treatments.
Terumo Interventional Systems continues to lead in minimally invasive intervention technologies, driven by robust research and development. The R2P NaviCross catheter not only addresses current clinical challenges but also anticipates future advancements in vascular access techniques. By expanding its product lineup, Terumo ensures that healthcare providers have access to innovative solutions that improve patient outcomes and streamline complex procedures.
The launch of the R2P NaviCross underscores Terumo’s dedication to enhancing clinical practice through cutting-edge medical devices. As the landscape of interventional cardiology evolves, Terumo remains at the forefront, delivering products that meet the highest standards of performance and reliability. Physicians can confidently rely on the R2P NaviCross to perform intricate radial-to-peripheral procedures, thereby advancing the quality of patient care across the globe.
This article has been prepared with the assistance of AI and reviewed by an editor. For more details, please refer to our Terms and Conditions. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author.
